[ad_1]
The “Pulmonary Drug Delivery Systems Market by Product, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030” report has been added to ResearchAndMarkets.com’s offering.
The global pulmonary drug delivery systems market was valued at $49782.76 million in 2020, and is estimated to reach $91,128.61 million by 2030, growing at a CAGR of 6.08% from 2021 to 2030.
Targeted drug delivery system (TDDS) is a system of directing the drug directly into its targeted body site. Pulmonary drug delivery system (PDDS) is a type of targeted drug delivery system in which medicine is administered by inhalation method. PDDS has an advantage of quick onset of action over any other route of administration and plays an important role in asthma and chronic obstructive pulmonary disease (COPD). PDDS is a special type of device that is known as Aerosol. It is a pressurized dosage form containing one or more drugs which upon actuation emits a fine dispersed liquid and/or solid materials in gaseous medium. By device, PDDS is divided into nebulizer, metered dose inhaler, and dry powder inhaler.
The growth of the global pulmonary drug delivery market is driven by the rise in air pollution, and technical advancements. Furthermore, the rise in smoking culture is responsible for …
Full story available on Benzinga.com
[ad_2]
Source link
